Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
---|
10/04/2012 | CA2831427A1 Prodrugs of d-isoglutamyl-[d/l]-tryptophan |
10/04/2012 | CA2830831A1 Macrocyclic compounds and methods for their production |
10/04/2012 | CA2830827A1 Macrocyclic compound and methods for its production |
10/03/2012 | EP2504344A1 Hepatitis c inhibitor compounds |
10/03/2012 | CN102712644A Novel macrocyclic inhibitors of hepatitis C virus replication |
10/03/2012 | CN102707070A Agent with kokumi |
10/03/2012 | CN102702311A Agent with kokumi |
10/03/2012 | CN102702310A Marine peptides compounds and application of marine peptides compounds to preparation of angiogenesis medicines |
10/03/2012 | CN102079771B Estrogen amino-acid ester compound with antitumor activity as well as synthetic method thereof |
10/03/2012 | CN101920196B Hydrogenation catalyst for synthesizing neotame and preparation method thereof |
10/03/2012 | CN101668778B Preparation of low bleeding anticoagulant fusion protein and its use |
10/03/2012 | CN101580535B Hcv protease inhibitors |
10/03/2012 | CN101400368B Cancer treatment using viruses, fluoropyrimidines and camptothecins |
10/02/2012 | CA2526629C Process and intermediates for the preparation of (1r,2s,5s)-3-azabicyclo[3,1,0]hexane-2-carboxamide, n-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2s)-2-[[[1,1-dimethylethyl]amino]carbonylamino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl |
09/27/2012 | WO2012129473A1 Gallium complexes, pharmaceutical compositions and methods of use |
09/27/2012 | WO2012128464A1 Undecenoyl dipeptide derivatives, and skin whitening cosmetic composition containing same |
09/27/2012 | WO2012128438A1 Palmitoyl dipeptide in which glycylproline or glycylhydroxyproline is bonded to palmitic acid, and a production method therefor |
09/27/2012 | US20120245091 Polypeptide or fused protein thereof inhibiting the extravasation of white blood cells or the growth and/or metastasis of cancer cells |
09/27/2012 | US20120244174 Treatment of tauopathies |
09/27/2012 | US20120244122 Peptides for the Treatment of HCV Infections |
09/26/2012 | EP2502906A2 Trypsin-like serine protease inhibitors, their preparation and use |
09/26/2012 | EP2501823A1 Method for the production of extracellular glutathione with high yields |
09/26/2012 | CN1914225B HCV NS-3 serine protease inhibitors |
09/26/2012 | CN102695714A Tubulin inhibitors |
09/26/2012 | CN102690327A Enterovirus 71 neutralized epitope polypeptide and application thereof |
09/26/2012 | CN102690326A Novel gossypol derivate with anti-HIV activity and preparation method thereof |
09/26/2012 | CN102690325A Synthesis of polypeptide PyroGlu-Pro-Arg-pNA.HCl |
09/26/2012 | CN101962400B Linear epitope minimum motif peptide of human papilloma virus type 58 L1 protein and application thereof |
09/25/2012 | US8273530 Method for simultaneous analysis of multiple biological reactions or changes in in vivo conditions |
09/25/2012 | CA2466591C Template-fixed peptidomimetics as inhibitors of serine proteases |
09/25/2012 | CA2405268C Dna molecules encoding l-glutamate-gated chloride channels from rhipicephalus sanguineus |
09/25/2012 | CA2336236C Mutations in and genomic structure of herg - a long qt syndrome gene |
09/20/2012 | WO2012123957A1 Oligopeptides and process for preparation thereof |
09/20/2012 | WO2012123423A1 N-carboxyalkyl-auristatins and use thereof |
09/20/2012 | WO2012098546A8 Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof |
09/20/2012 | WO2012076985A8 Granzyme b inhibitor compositions, methods and uses for promoting wound healing |
09/20/2012 | US20120238749 Inhibitors of interleukin-1 beta converting enzyme |
09/20/2012 | US20120238503 Human laminin alpha2 chain lg3 domain and active peptides promoting cell adhesion, spreading, migration, and neurite outgrowth |
09/20/2012 | US20120237552 Peptoid Agonists of Nerve Growth Factor and Their Use as Medicaments |
09/20/2012 | CA2829736A1 N-carboxyalkylauristatins and use thereof |
09/19/2012 | EP2500029A1 Therapeutic agent for gastrointestinal diseases |
09/19/2012 | EP2499153A1 Tubulin inhibitors |
09/19/2012 | EP2499152A1 Tubulin inhibitors |
09/19/2012 | CN102686602A Lanthionine derivative |
09/19/2012 | CN102675418A Luteinizing hormone-releasing hormone (LHRH) antagonist derivative, preparation method of LHRH antagonist derivative and application of LHRH antagonist derivative |
09/19/2012 | CN102675417A Monocyte migration inhibition factor analogue, synthesis thereof and application thereof |
09/19/2012 | CN102675416A Beta-carboline derivatives, and preparation method and application thereof |
09/19/2012 | CN102675415A Method for preparing bortezomib |
09/19/2012 | CN102671181A High purity lipopeptides, lipopeptide micelles and processes for preparing same |
09/18/2012 | US8268798 Low density lipoprotein receptor-mediated siRNA delivery |
09/18/2012 | CA2451133C Therapeutic agent for sepsis |
09/18/2012 | CA2410662C Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
09/13/2012 | WO2012121428A1 Fibroblast growth composition comprising a dipeptide as an active ingredient, and a product comprising the composition |
09/13/2012 | US20120232248 Therapeutic agent for pulmonary small cell carcinoma |
09/13/2012 | US20120232247 Processes for preparing protease inhibitors of hepatitis c virus |
09/13/2012 | DE102011005288A1 Producing protein hydrolyzate, useful as angiotensin converting enzyme inhibitor, comprises enzymatically hydrolyzing protein containing substrate in two treatment steps with different proteolytic enzymes |
09/12/2012 | EP2497765A1 Process for preparing creatine amides |
09/12/2012 | EP2496596A1 Therapeutic peptides |
09/12/2012 | CN102665768A Peptide clearing agents |
09/12/2012 | CN102665749A Anti-inflammatory agent for oral application, and anti-inflammatory peptide for oral application |
09/12/2012 | CN102665452A Extracts and beverages containing 2, 5-piperazinedione, 3, 6-bis (phenylmethyl) -, (3s, 6s) - |
09/12/2012 | CN102665451A Acidic extracts and beverages containing 2,5-piperazinedione,3,6-bis(phenylmethyl)-,(3s,6s)- |
09/12/2012 | CN102660615A Antioxidant peptide and preparation method thereof |
09/12/2012 | CN102659920A C-end phenylalanine p-amino modified endomorphine-1 analog and preparation and application thereof |
09/12/2012 | CN102659919A Synthetic method of bortezomib |
09/12/2012 | CN102659918A Graphene/dipeptide self-assembly composite film and preparation method thereof |
09/12/2012 | CN102241674B Synthesis method and antitumor activity evaluation of 1,1-dimethyl-beta-carboline-3-formacyl amino acid benzyl ester |
09/11/2012 | US8263738 Estrogen receptors and methods of use |
09/11/2012 | US8263548 Metal-binding compounds and uses therefor |
09/11/2012 | US8263547 DISC-1 pathway activators in the control of neurogenesis |
09/11/2012 | CA2549851C Macrocyclic peptides active against the hepatitis c virus |
09/11/2012 | CA2465245C Biologically active peptides and their use for repairing injured nerves |
09/07/2012 | WO2012117136A1 Lactoferrin hydrolysate fraction with a low molecular weight for treating hypertension |
09/07/2012 | WO2012097333A3 Aldehyde-tagged immunoglobulin polypeptides and method of use thereof |
09/07/2012 | WO2012047354A3 Environmentally sensitive compositions |
09/06/2012 | US20120226072 Processes for intermediates for macrocyclic compounds |
09/06/2012 | US20120226067 Processes for intermediates for macrocyclic compounds |
09/06/2012 | US20120226066 Processes for intermediates for macrocyclic compounds |
09/06/2012 | US20120225830 Method of producing fr901228 |
09/06/2012 | US20120225829 Method of producing fr901228 |
09/06/2012 | US20120225817 Therapeutic agent for gastrointestinal disease |
09/05/2012 | EP2495250A2 Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same |
09/05/2012 | EP2495249A1 Tertiary amine substituted peptides useful as inhibitors of HCV replication |
09/05/2012 | EP2493910A1 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same |
09/05/2012 | CN1956994B Epithelial cell growth promoter |
09/05/2012 | CN101899084B (3S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid kyrine conjugate, preparation method and application thereof |
09/05/2012 | CN101696231B Antigen epitope minimum motif peptide of human papilloma virus 58 type E6 protein |
09/05/2012 | CN101627049B Synthetic peptide amides |
09/04/2012 | US8258256 Compositions and methods for the treatment of cancer |
09/04/2012 | US8258101 Peptide-based compounds |
09/04/2012 | US8257943 Process for producing dipeptides or dipeptide derivatives |
09/04/2012 | CA2615022C Hcv ns3 protease inhibitors |
08/30/2012 | US20120220752 Tri-amino releasing fulvate |
08/30/2012 | US20120219501 Biomarker en2 for gynaecological cancer |
08/30/2012 | US20120219498 Compositions and methods for inducing angiogenesis |
08/29/2012 | EP2492278A1 Antibodies against an agonist of G-protein coupled receptors and its use indiagnosis and therapy |
08/29/2012 | EP2491943A2 Methods for preventing mitochondrial permeability transition |
08/29/2012 | EP2491051A2 Gadd45beta targeting agents |
08/29/2012 | EP2490766A1 Non-natural macrocyclic amide hdac6 inhibitor compounds and their uses as therapeutic agents |
08/29/2012 | EP2008664B1 Modified proteins which bind extracellular matrix components |